WO2004069795A3 - Diagnosis and treatment of chronic tissue damage - Google Patents

Diagnosis and treatment of chronic tissue damage Download PDF

Info

Publication number
WO2004069795A3
WO2004069795A3 PCT/US2004/002881 US2004002881W WO2004069795A3 WO 2004069795 A3 WO2004069795 A3 WO 2004069795A3 US 2004002881 W US2004002881 W US 2004002881W WO 2004069795 A3 WO2004069795 A3 WO 2004069795A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnosis
tissue damage
treatment
chronic tissue
chronic
Prior art date
Application number
PCT/US2004/002881
Other languages
French (fr)
Other versions
WO2004069795A2 (en
Inventor
Richard Butt
Klaus Rumpel
Bryn I Williams-Jones
Herath Mudiyanselage At Herath
Christian Rohlff
James A Bruce
Thakorbhai P Patel
Original Assignee
Pfizer Prod Inc
Oxford Glycosciences Uk Ltd
Richard Butt
Klaus Rumpel
Bryn I Williams-Jones
Herath Mudiyanselage At Herath
Christian Rohlff
James A Bruce
Thakorbhai P Patel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc, Oxford Glycosciences Uk Ltd, Richard Butt, Klaus Rumpel, Bryn I Williams-Jones, Herath Mudiyanselage At Herath, Christian Rohlff, James A Bruce, Thakorbhai P Patel filed Critical Pfizer Prod Inc
Publication of WO2004069795A2 publication Critical patent/WO2004069795A2/en
Publication of WO2004069795A3 publication Critical patent/WO2004069795A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

This invention relates to use of proteins associated with chronic tissue damage, e.g., chronic dermal ulcers. The proteins identified are useful for clinical screening, diagnosis, prognosis, therapy, and prophylaxis, as well as for drug screening and drug development.
PCT/US2004/002881 2003-02-03 2004-02-02 Diagnosis and treatment of chronic tissue damage WO2004069795A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44460003P 2003-02-03 2003-02-03
US60/444,600 2003-02-03

Publications (2)

Publication Number Publication Date
WO2004069795A2 WO2004069795A2 (en) 2004-08-19
WO2004069795A3 true WO2004069795A3 (en) 2007-08-09

Family

ID=32850892

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/002881 WO2004069795A2 (en) 2003-02-03 2004-02-02 Diagnosis and treatment of chronic tissue damage

Country Status (1)

Country Link
WO (1) WO2004069795A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6897039B2 (en) * 2000-11-10 2005-05-24 Proteopharma Aps Apolipoprotein analogues

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6897039B2 (en) * 2000-11-10 2005-05-24 Proteopharma Aps Apolipoprotein analogues

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 20 September 2001 (2001-09-20), accession no. EMBL Database accession no. (ABB56060) *
ENGWEGEN J. ET AL.: "Identification of serum proteins discriminating colorectal cancer patients and healthy controle using surface-enhanced laser desorption ionisation-time of flight mass spectrometry", WORLD J GASTOENTEROL, vol. 12, no. 10, March 2006 (2006-03-01), pages 1536 - 1544, XP009075698 *
WAN J. ET AL.: "Inflammation inhibitors were remarkably up-regulated in plasma of severe acute respiratory syndrome patients at progressive phase", vol. 6, no. 9, April 2006 (2006-04-01), pages 2886 - 2894 *

Also Published As

Publication number Publication date
WO2004069795A2 (en) 2004-08-19

Similar Documents

Publication Publication Date Title
AU2003293460A1 (en) Novel application of biosensors for diagnosis and treatment of disease
WO2006035237A3 (en) Methods and compositions relating to alzheimer's disease
WO2004092215A3 (en) Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
WO2007007173A3 (en) Human anti-madcam antibodies
WO2006015035A8 (en) Useful compounds for hpv infection
WO2004030615A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004016225A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003087831A3 (en) Proteins involved in breast cancer
AU2003300368A1 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
CO5660287A2 (en) DERIVATIVES OF TETRAHYDROCARBAZOL AND ITS PHARMACEUTICAL USE
WO2004071382A3 (en) Substituted heterocycles
WO2003057160A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2006027693A3 (en) Tumor specific genes and variant RNAS and uses thereof as targets for cancer therapy and diagnosis
AU2002338852A1 (en) Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease
CY1111353T1 (en) USE OF KALALIDIS COMPOUNDS FOR PRODUCTION OF MEDICINE FOR TREATMENT OF PORCELAIN
AU2003229284A1 (en) Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur
WO2005003154A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2001071357A3 (en) Diagnosis and treatment of breast cancer
ATE506961T1 (en) CCN3 PROTEINS FOR THE TREATMENT AND DIAGNOSIS OF KIDNEY DISEASES
WO2004033660A3 (en) Gene expression profiling from ffpe samples
WO2006002846A3 (en) New analogs of nitrobenzylthioinosine
AU2003237792A1 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004005540A3 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
WO2004069795A3 (en) Diagnosis and treatment of chronic tissue damage
IL174134A0 (en) Use of a protein in the preparation of a medicament for treatment of fibrotic diseases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct application non-entry in european phase